Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001638599-18-000707
Filing Date
2018-07-02
Accepted
2018-07-02 16:05:34
Documents
1
Period of Report
2018-06-28

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT doc4_5504.html 4  
1 PRIMARY DOCUMENT doc4_5504.xml 4 10292
  Complete submission text file 0001638599-18-000707.txt   11603
Mailing Address 8748 TECHNOLOGY WAY RENO NV 89521
Business Address 8748 TECHNOLOGY WAY RENO NV 89521 813-766-9539
EYENOVIA, INC. (Issuer) CIK: 0001682639 (see all company filings)

EIN.: 471178401 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 501 FIFTH AVENUE SUITE 1404 NEW YORK NY 10017
Business Address
Ianchulev Tsontcho (Reporting) CIK: 0001728916 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38365 | Film No.: 18932705